NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $676,758 | -65.4% | 6,644 | -65.7% | 0.11% | -45.9% |
| Q2 2023 | $1,955,232 | +17.6% | 19,376 | +7.2% | 0.20% | +9.6% |
| Q1 2023 | $1,663,176 | -36.8% | 18,078 | -37.7% | 0.19% | -42.3% |
| Q4 2022 | $2,630,517 | +33.5% | 28,996 | +11.8% | 0.32% | +20.4% |
| Q3 2022 | $1,971,000 | -16.4% | 25,933 | -7.1% | 0.27% | -12.9% |
| Q2 2022 | $2,359,000 | +6.9% | 27,912 | +11.0% | 0.31% | +26.6% |
| Q1 2022 | $2,207,000 | +18.7% | 25,149 | +18.3% | 0.24% | +22.0% |
| Q4 2021 | $1,860,000 | +1.1% | 21,261 | -5.4% | 0.20% | -17.7% |
| Q3 2021 | $1,839,000 | +6.5% | 22,483 | +18.9% | 0.24% | -12.6% |
| Q2 2021 | $1,726,000 | +12.4% | 18,914 | +5.2% | 0.28% | -11.7% |
| Q1 2021 | $1,536,000 | +132.0% | 17,974 | +156.5% | 0.32% | +54.4% |
| Q4 2020 | $662,000 | – | 7,008 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |